TY -的T1 -吸入和之间的关系ticosteroid and osteoporosis and fracture JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00216-2021 VL - 57 IS - 6 SP - 2100216 AU - Wang, Cheng-Yi AU - Lai, Chih-Cheng Y1 - 2021/06/01 UR - //www.qdcxjkg.com/content/57/6/2100216.abstract N2 - We read with great interest the study investigating the association between inhaled corticosteroid (ICS) and the risk of osteoporosis and fracture among COPD patients [1]. Multivariate analysis in this study demonstrated a significant dose–effect relationship between ICS and the risk of osteoporosis-related events. Compared to non-ICS users, high-dose ICS treatment was significantly associated with any osteoporosis-related event (risk ratio 1.52, 95% CI 1.24–1.62; while the corresponding estimate for low-dose ICS was 1.27, 95% CI 1.13–1.56) [1]. Overall, it is a well-designed study; however, we have one major and two minor concerns about the findings of this study.More analysis is needed to assess the impact of inhaled corticosteroid on osteoporosis https://bit.ly/3u7qzpg ER -